Search results
Big Pharma Has the Firepower for Biotech Deal-Making
ETF Trends· 1 day agoIn the early innings of 2024, there was a flurry of consolidation in the biotech industry. It stoked hopes that this would finally be the year in which...
Head to Head Survey: Evaxion Biotech A/S (NASDAQ:EVAX) and Halozyme Therapeutics (NASDAQ:HALO)
ETF DAILY NEWS· 2 days agoHalozyme Therapeutics (NASDAQ:HALO – Get Free Report) and Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) are both medical companies, but which is the superior
Options Solutions LLC Reduces Stock Position in Colgate-Palmolive (NYSE:CL)
ETF DAILY NEWS· 11 hours agoThe institutional investor owned 8,605 shares of the company’s stock after selling 798 shares during...
Auxier Asset Management Decreases Stock Holdings in McDonald’s Co. (NYSE:MCD)
ETF DAILY NEWS· 7 hours agoFinancial Engines Advisors L.L.C. increased its position in shares of McDonald’s by 47.2% during the 3rd quarter. Financial Engines Advisors L.L.C. now owns 1,191 shares of the fast-food giant ...
Walmart (NYSE:WMT) Stock Price Down 0.2% After Insider Selling
ETF DAILY NEWS· 16 hours agoSpecifically, major shareholder Alice L. Walton sold 1,132,123 shares of Walmart stock in a...
Why Moderna Stock Is a No-Brainer Buy Right Now
The Motley Fool via AOL· 5 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only $4 billion this year. The real story for Moderna is much better than that ...
This High-Flying Stock Just Announced More Good News: Time to Buy? | The Motley Fool
The Motley Fool· 6 days agoThe biotech industry features many prominent companies that command plenty of attention on the...
Biotech Catapults On 'Unprecedented' Results For Gel-Based Drug
Investor's Business Daily· 2 days agoAfter three months, 79.6% of patients treated with UroGen Pharma's (URGN) drug had a complete...
The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A Record
Investor's Business Daily· 3 days agoAvidity Biosciences unveiled "impressive" results from a study of its treatment for a rare form of...
Is It Time to Buy May's Worst-Performing Nasdaq Stocks?
Motley Fool via Yahoo Finance· 2 days agoMDB data by YCharts Could this biotech company triple in value? Exact Sciences (NASDAQ: EXAS) is...
